A major advance in cancer investigation is emerging with the use of VHH fragments to re-engage dysfunctional p53. This vital malignant suppressor protein is frequently lost in many forms of malignancies, resulting https://socials360.com/story12629606/mini-antibodies-revive-tumor-suppressor-p53-a-new-approach-for-malignant-management